aliquot

Incretin-related

Pramlintide

A web reference identity with a historical FDA label and route-specific human pharmacokinetic information.

Canonical ID
pramlintide
Evidence type
Historical FDA regulatory record
Human PK
48 minutes

Overview

Aliquot preserves the source’s historical warning instead of presenting an older label as proof of current product status.

The reviewed label reports a human half-life, but it also states that it may not be the latest approved labeling. Aliquot does not infer current marketing or product availability.

Human pharmacokinetic context

48 minutes

Historical FDA prescribing information · subcutaneous injection

Half-life is descriptive population context, not a dosing interval, a prediction of an individual's response, or a recommendation. Route-mismatched and uncited estimates are withheld.

Limitations

  • The reviewed label is dated 2014 and explicitly directs readers to check current FDA labeling.
  • This page does not establish current product availability or marketing status.
  • A population half-life is not an individual prediction or a dosing interval.

Related calculation tools

Aliquot's browser-only tools transform values you already have. They do not select a compound, suggest an amount, provide presets, or store your entries.

View all tools Convert mg and mcg

Sources

  1. Symlin (pramlintide acetate) prescribing information Historical FDA prescribing information · U.S. Food and Drug Administration · accessed 2026-07-28 Historical regulatory record and approximately 48-minute half-life in healthy individuals.
  2. Aliquot compound library methodology Editorial methodology · Aliquot · accessed 2026-07-28 Editorial scope and historical-source rules.

Aliquot Compound Library

Before you browse

Aliquot's Compound Library is an educational reference. Here is how to read and use it.

Educational, not medical advice

The library does not diagnose, treat, prevent, recommend a compound, or replace a licensed clinician. Consult a qualified clinician for personal health decisions.

Evidence has boundaries

Summaries draw from cited public regulator records, peer-reviewed human studies, PubMed records, and trial registrations. A citation does not make a claim conclusive.

No community health profiles

Aliquot does not collect community protocols or outcomes for this library. Calculator entries remain in your browser tab and are not submitted or saved.

Content and reuse

Aliquot's original editorial text and presentation may not be copied, scraped, mirrored, or redistributed without written permission. Linked sources remain subject to their publishers' terms.

This acknowledgement is stored only in this browser. No health or calculator data is included.

Methodology Terms

Reviewed by Aliquot editorial review on 2026-07-28. Next scheduled review: 2026-10-26. Methodology and corrections.